Listed

American Shared Hospital Services

AMSNYSECIK 744825HealthcareFiscal year ends Dec 31

Latest reported revenue, Q2 FY2026$8.4mRevenue, Q2 FY2026, three months to 2026-06-30$8.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001437749-26-027716.Report this figureThree months to Jun 30, 2026, from the 10-Q filed Aug 13, 2026.

Latest quarter: Q2 FY2026

Three months to Jun 30, 2026, against the same quarter a year earlier.

  • Revenue$8.4mRevenue, Q2 FY2026, three months to 2026-06-30$8.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001437749-26-027716.Report this figure+19.2% on a year earlier
  • Gross margin17.0%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $1.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-13, accession 0001437749-26-027716.Revenue: $8.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001437749-26-027716.Report this figure−6.1 pts on a year earlier
  • Operating margin−10.8%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: −$910.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001437749-26-027716.Revenue: $8.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001437749-26-027716.Report this figure−3.1 pts on a year earlier
  • Net margin−6.1%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: −$514.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001437749-26-027716.Revenue: $8.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001437749-26-027716.Report this figure−2.1 pts on a year earlier
  • Diluted EPS−$0.07Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001437749-26-027716.Report this figure−75.0% on a year earlier
  • Free cash flow$2.2mFree cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: $2.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001437749-26-027716. Derived: 6-month figure less the 3-month figure.Capital expenditure: $58.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001437749-26-027716. Derived: 6-month figure less the 3-month figure.Report this figureSign changed from a year earlier

Last eight quarters

Full statements
Revenue$8.4mGross margin 17.0%
Diluted EPS−$0.07, Q2 FY2026
Free cash flow$2.2m, Q2 FY2026
American Shared Hospital Services, key figures for the last eight quarters
Line itemUnitQ3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Shape over the periods
Revenue$k6,999Revenue, Q3 FY2024, three months to 2024-09-30$7.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q/A filed 2026-01-16, accession 0001437749-26-001452.Report this figure9,069Revenue, Q4 FY2024, three months to 2024-12-31$9.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001437749-26-010731. Derived: 12-month figure less the 9-month figure.Report this figure6,112Revenue, Q1 FY2025, three months to 2025-03-31$6.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-14, accession 0001437749-26-017046.Report this figure7,071Revenue, Q2 FY2025, three months to 2025-06-30$7.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001437749-26-027716.Report this figure7,171Revenue, Q3 FY2025, three months to 2025-09-30$7.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q/A filed 2026-01-16, accession 0001437749-26-001452.Report this figure7,728Revenue, Q4 FY2025, three months to 2025-12-31$7.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001437749-26-010731. Derived: 12-month figure less the 9-month figure.Report this figure7,084Revenue, Q1 FY2026, three months to 2026-03-31$7.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-14, accession 0001437749-26-017046.Report this figure8,430Revenue, Q2 FY2026, three months to 2026-06-30$8.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001437749-26-027716.Report this figure
Gross margin%19.6%Gross margin, Q3 FY2024, three months to 2024-09-30. gross profit / revenueGross profit: $1.4m. XBRL concept us-gaap:GrossProfit. 10-Q/A filed 2026-01-16, accession 0001437749-26-001452.Revenue: $7.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q/A filed 2026-01-16, accession 0001437749-26-001452.Report this figure35.3%Gross margin, Q4 FY2024, three months to 2024-12-31. gross profit / revenueGross profit: $3.2m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-31, accession 0001437749-26-010731. Derived: 12-month figure less the 9-month figure.Revenue: $9.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001437749-26-010731. Derived: 12-month figure less the 9-month figure.Report this figure15.4%Gross margin, Q1 FY2025, three months to 2025-03-31. gross profit / revenueGross profit: $942.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-14, accession 0001437749-26-017046.Revenue: $6.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-14, accession 0001437749-26-017046.Report this figure23.1%Gross margin, Q2 FY2025, three months to 2025-06-30. gross profit / revenueGross profit: $1.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-13, accession 0001437749-26-027716.Revenue: $7.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001437749-26-027716.Report this figure22.1%Gross margin, Q3 FY2025, three months to 2025-09-30. gross profit / revenueGross profit: $1.6m. XBRL concept us-gaap:GrossProfit. 10-Q/A filed 2026-01-16, accession 0001437749-26-001452.Revenue: $7.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q/A filed 2026-01-16, accession 0001437749-26-001452.Report this figure11.7%Gross margin, Q4 FY2025, three months to 2025-12-31. gross profit / revenueGross profit: $906.0k. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-31, accession 0001437749-26-010731. Derived: 12-month figure less the 9-month figure.Revenue: $7.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001437749-26-010731. Derived: 12-month figure less the 9-month figure.Report this figure18.2%Gross margin, Q1 FY2026, three months to 2026-03-31. gross profit / revenueGross profit: $1.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-14, accession 0001437749-26-017046.Revenue: $7.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-14, accession 0001437749-26-017046.Report this figure17.0%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $1.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-13, accession 0001437749-26-027716.Revenue: $8.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001437749-26-027716.Report this figure
Operating margin%(12.7%)Operating margin, Q3 FY2024, three months to 2024-09-30. operating income / revenueOperating income: −$889.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q/A filed 2026-01-16, accession 0001437749-26-001452.Revenue: $7.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q/A filed 2026-01-16, accession 0001437749-26-001452.Report this figure(20.2%)Operating margin, Q4 FY2024, three months to 2024-12-31. operating income / revenueOperating income: −$1.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-31, accession 0001437749-26-010731. Derived: 12-month figure less the 9-month figure.Revenue: $9.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001437749-26-010731. Derived: 12-month figure less the 9-month figure.Report this figure(21.3%)Operating margin, Q1 FY2025, three months to 2025-03-31. operating income / revenueOperating income: −$1.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001437749-26-017046.Revenue: $6.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-14, accession 0001437749-26-017046.Report this figure(7.7%)Operating margin, Q2 FY2025, three months to 2025-06-30. operating income / revenueOperating income: −$544.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001437749-26-027716.Revenue: $7.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001437749-26-027716.Report this figure(4.8%)Operating margin, Q3 FY2025, three months to 2025-09-30. operating income / revenueOperating income: −$344.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q/A filed 2026-01-16, accession 0001437749-26-001452.Revenue: $7.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q/A filed 2026-01-16, accession 0001437749-26-001452.Report this figure(18.1%)Operating margin, Q4 FY2025, three months to 2025-12-31. operating income / revenueOperating income: −$1.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-31, accession 0001437749-26-010731. Derived: 12-month figure less the 9-month figure.Revenue: $7.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001437749-26-010731. Derived: 12-month figure less the 9-month figure.Report this figure(13.0%)Operating margin, Q1 FY2026, three months to 2026-03-31. operating income / revenueOperating income: −$924.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001437749-26-017046.Revenue: $7.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-14, accession 0001437749-26-017046.Report this figure(10.8%)Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: −$910.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001437749-26-027716.Revenue: $8.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001437749-26-027716.Report this figure
Net margin%(3.0%)Net margin, Q3 FY2024, three months to 2024-09-30. net income / revenueNet income: −$207.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q/A filed 2026-01-16, accession 0001437749-26-001452.Revenue: $7.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q/A filed 2026-01-16, accession 0001437749-26-001452.Report this figure(14.6%)Net margin, Q4 FY2024, three months to 2024-12-31. net income / revenueNet income: −$1.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-31, accession 0001437749-26-010731. Derived: 12-month figure less the 9-month figure.Revenue: $9.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001437749-26-010731. Derived: 12-month figure less the 9-month figure.Report this figure(10.2%)Net margin, Q1 FY2025, three months to 2025-03-31. net income / revenueNet income: −$625.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-14, accession 0001437749-26-017046.Revenue: $6.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-14, accession 0001437749-26-017046.Report this figure(4.0%)Net margin, Q2 FY2025, three months to 2025-06-30. net income / revenueNet income: −$280.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001437749-26-027716.Revenue: $7.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001437749-26-027716.Report this figure(0.2%)Net margin, Q3 FY2025, three months to 2025-09-30. net income / revenueNet income: −$17.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q/A filed 2026-01-16, accession 0001437749-26-001452.Revenue: $7.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q/A filed 2026-01-16, accession 0001437749-26-001452.Report this figure(8.2%)Net margin, Q4 FY2025, three months to 2025-12-31. net income / revenueNet income: −$631.0k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-31, accession 0001437749-26-010731. Derived: 12-month figure less the 9-month figure.Revenue: $7.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001437749-26-010731. Derived: 12-month figure less the 9-month figure.Report this figure(8.6%)Net margin, Q1 FY2026, three months to 2026-03-31. net income / revenueNet income: −$612.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-14, accession 0001437749-26-017046.Revenue: $7.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-14, accession 0001437749-26-017046.Report this figure(6.1%)Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: −$514.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001437749-26-027716.Revenue: $8.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001437749-26-027716.Report this figure
Diluted EPS$ per share(0.03)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q/A filed 2026-01-16, accession 0001437749-26-001452.Report this figurenot reported (Diluted EPS not reported)(0.10)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001437749-26-017046.Report this figure(0.04)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.04 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001437749-26-027716.Report this figure0.00Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q/A filed 2026-01-16, accession 0001437749-26-001452.Report this figurenot reported (Diluted EPS not reported)(0.09)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001437749-26-017046.Report this figure(0.07)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001437749-26-027716.Report this figure
Free cash flow$k(407)Free cash flow, Q3 FY2024, three months to 2024-09-30. operating cash flow − capital expenditureOperating cash flow: $472.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q/A filed 2026-01-16, accession 0001437749-26-001452. Derived: 9-month figure less the 6-month figure.Capital expenditure: $879.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q/A filed 2026-01-16, accession 0001437749-26-001452. Derived: 9-month figure less the 6-month figure.Report this figure(4,386)Free cash flow, Q4 FY2024, three months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $274.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-31, accession 0001437749-26-010731. Derived: 12-month figure less the 9-month figure.Capital expenditure: $4.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-31, accession 0001437749-26-010731. Derived: 12-month figure less the 9-month figure.Report this figure(1,512)Free cash flow, Q1 FY2025, three months to 2025-03-31. operating cash flow − capital expenditureOperating cash flow: $2.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001437749-26-017046.Capital expenditure: $4.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-14, accession 0001437749-26-017046.Report this figure(2,273)Free cash flow, Q2 FY2025, three months to 2025-06-30. operating cash flow − capital expenditureOperating cash flow: −$372.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001437749-26-027716. Derived: 6-month figure less the 3-month figure.Capital expenditure: $1.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001437749-26-027716. Derived: 6-month figure less the 3-month figure.Report this figure(2,031)Free cash flow, Q3 FY2025, three months to 2025-09-30. operating cash flow − capital expenditureOperating cash flow: $1.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q/A filed 2026-01-16, accession 0001437749-26-001452. Derived: 9-month figure less the 6-month figure.Capital expenditure: $3.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q/A filed 2026-01-16, accession 0001437749-26-001452. Derived: 9-month figure less the 6-month figure.Report this figure(2,688)Free cash flow, Q4 FY2025, three months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: −$704.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-31, accession 0001437749-26-010731. Derived: 12-month figure less the 9-month figure.Capital expenditure: −$2.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-31, accession 0001437749-26-010731. Derived: 12-month figure less the 9-month figure.Report this figure2,108Free cash flow, Q1 FY2026, three months to 2026-03-31. operating cash flow − capital expenditureOperating cash flow: $2.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001437749-26-017046.Capital expenditure: $41.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-14, accession 0001437749-26-017046.Report this figure2,178Free cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: $2.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001437749-26-027716. Derived: 6-month figure less the 3-month figure.Capital expenditure: $58.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001437749-26-027716. Derived: 6-month figure less the 3-month figure.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$28.1mGross margin 18.0%
Diluted EPS−$0.23, FY2025
Free cash flow−$4.5m, FY2025
American Shared Hospital Services, key figures for the last five fiscal years
Line itemUnitFY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31Shape over the periods
Revenue$m17.6Revenue, FY2021, twelve months to 2021-12-31$17.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2023-03-31, accession 0001437749-23-008796.Report this figure19.7Revenue, FY2022, twelve months to 2022-12-31$19.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-04-01, accession 0001437749-24-010308.Report this figure21.3Revenue, FY2023, twelve months to 2023-12-31$21.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-04-04, accession 0001437749-25-011052.Report this figure28.3Revenue, FY2024, twelve months to 2024-12-31$28.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001437749-26-010731.Report this figure28.1Revenue, FY2025, twelve months to 2025-12-31$28.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001437749-26-010731.Report this figure
Gross margin%38.2%Gross margin, FY2021, twelve months to 2021-12-31. gross profit / revenueGross profit: $6.7m. XBRL concept us-gaap:GrossProfit. 10-K filed 2023-03-31, accession 0001437749-23-008796.Revenue: $17.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2023-03-31, accession 0001437749-23-008796.Report this figure42.4%Gross margin, FY2022, twelve months to 2022-12-31. gross profit / revenueGross profit: $8.4m. XBRL concept us-gaap:GrossProfit. 10-K filed 2024-04-01, accession 0001437749-24-010308.Revenue: $19.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-04-01, accession 0001437749-24-010308.Report this figure43.8%Gross margin, FY2023, twelve months to 2023-12-31. gross profit / revenueGross profit: $9.3m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-04-04, accession 0001437749-25-011052.Revenue: $21.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-04-04, accession 0001437749-25-011052.Report this figure32.4%Gross margin, FY2024, twelve months to 2024-12-31. gross profit / revenueGross profit: $9.2m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-31, accession 0001437749-26-010731.Revenue: $28.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001437749-26-010731.Report this figure18.0%Gross margin, FY2025, twelve months to 2025-12-31. gross profit / revenueGross profit: $5.1m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-31, accession 0001437749-26-010731.Revenue: $28.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001437749-26-010731.Report this figure
Operating margin%7.7%Operating margin, FY2021, twelve months to 2021-12-31. operating income / revenueOperating income: $1.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2023-03-31, accession 0001437749-23-008796.Revenue: $17.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2023-03-31, accession 0001437749-23-008796.Report this figure12.3%Operating margin, FY2022, twelve months to 2022-12-31. operating income / revenueOperating income: $2.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-04-01, accession 0001437749-24-010308.Revenue: $19.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-04-01, accession 0001437749-24-010308.Report this figure1.3%Operating margin, FY2023, twelve months to 2023-12-31. operating income / revenueOperating income: $270.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-04-04, accession 0001437749-25-011052.Revenue: $21.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-04-04, accession 0001437749-25-011052.Report this figure(9.9%)Operating margin, FY2024, twelve months to 2024-12-31. operating income / revenueOperating income: −$2.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-31, accession 0001437749-26-010731.Revenue: $28.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001437749-26-010731.Report this figure(12.8%)Operating margin, FY2025, twelve months to 2025-12-31. operating income / revenueOperating income: −$3.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-31, accession 0001437749-26-010731.Revenue: $28.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001437749-26-010731.Report this figure
Net margin%1.1%Net margin, FY2021, twelve months to 2021-12-31. net income / revenueNet income: $194.0k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2023-03-31, accession 0001437749-23-008796.Revenue: $17.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2023-03-31, accession 0001437749-23-008796.Report this figure6.7%Net margin, FY2022, twelve months to 2022-12-31. net income / revenueNet income: $1.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-04-01, accession 0001437749-24-010308.Revenue: $19.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-04-01, accession 0001437749-24-010308.Report this figure2.9%Net margin, FY2023, twelve months to 2023-12-31. net income / revenueNet income: $610.0k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-04-04, accession 0001437749-25-011052.Revenue: $21.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-04-04, accession 0001437749-25-011052.Report this figure7.7%Net margin, FY2024, twelve months to 2024-12-31. net income / revenueNet income: $2.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-31, accession 0001437749-26-010731.Revenue: $28.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001437749-26-010731.Report this figure(5.5%)Net margin, FY2025, twelve months to 2025-12-31. net income / revenueNet income: −$1.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-31, accession 0001437749-26-010731.Revenue: $28.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001437749-26-010731.Report this figure
Diluted EPS$ per share0.03Diluted EPS, FY2021, twelve months to 2021-12-31$0.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2023-03-31, accession 0001437749-23-008796.Report this figure0.21Diluted EPS, FY2022, twelve months to 2022-12-31$0.21 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-04-01, accession 0001437749-24-010308.Report this figure0.10Diluted EPS, FY2023, twelve months to 2023-12-31$0.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-04-04, accession 0001437749-25-011052.Report this figure0.33Diluted EPS, FY2024, twelve months to 2024-12-31$0.33 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-31, accession 0001437749-26-010731.Report this figure(0.23)Diluted EPS, FY2025, twelve months to 2025-12-31−$0.23 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-31, accession 0001437749-26-010731.Report this figure
Free cash flow$m4.6Free cash flow, FY2021, twelve months to 2021-12-31. operating cash flow − capital expenditureOperating cash flow: $6.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2023-03-31, accession 0001437749-23-008796.Capital expenditure: $1.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2023-03-31, accession 0001437749-23-008796.Report this figure6.8Free cash flow, FY2022, twelve months to 2022-12-31. operating cash flow − capital expenditureOperating cash flow: $7.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-04-01, accession 0001437749-24-010308.Capital expenditure: $388.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-04-01, accession 0001437749-24-010308.Report this figure(0.6)Free cash flow, FY2023, twelve months to 2023-12-31. operating cash flow − capital expenditureOperating cash flow: $5.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-04-04, accession 0001437749-25-011052.Capital expenditure: $6.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-04-04, accession 0001437749-25-011052.Report this figure(7.8)Free cash flow, FY2024, twelve months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $167.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-31, accession 0001437749-26-010731.Capital expenditure: $7.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-31, accession 0001437749-26-010731.Report this figure(4.5)Free cash flow, FY2025, twelve months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $3.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-31, accession 0001437749-26-010731.Capital expenditure: $7.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-31, accession 0001437749-26-010731.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding American Shared Hospital Services
FundQuarter endedReported valueSharesPut or callChange on the quarter before
DIMENSIONAL FUND ADVISORS LP2026-06-30$161.4k102,140Reduced−102,980
LPL Financial LLC2026-06-30$128.6k81,386Added+5,020
RENAISSANCE TECHNOLOGIES LLC2026-06-30$91.2k57,695Added+8,495
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$87.9k55,662Reduced−98,075
JAMES INVESTMENT RESEARCH, INC.2026-06-30$47.0k29,725Unchanged
NewEdge Advisors, LLC2026-06-30$47.0k29,725Unchanged
BRIDGEWAY CAPITAL MANAGEMENT, LLC2026-06-30$46.0k29,124Reduced−61,696
GEODE CAPITAL MANAGEMENT, LLC2026-06-30$41.9k26,497Reduced−6,091
VANGUARD FIDUCIARY TRUST CO2026-06-30$40.1k25,363Reduced−2,043
XTX Topco Ltd2026-06-30$30.2k19,107New+19,107

Recent filings

All 524 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

American Shared Hospital Services, recent filings
FiledFormWhat it isAccession number
2026-08-1316:41 ET10-QQuarterly reportPeriod 2026-06-300001437749-26-027716
2026-08-1312:44 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001437749-26-027549
2026-07-3020:30 ETSCHEDULE 13D/AOwnership report, active investor, amended0001437749-26-025133
2026-07-2816:21 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001437749-26-024677
2026-07-1316:16 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001437749-26-023433
2026-06-3013:34 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results0001437749-26-022119
2026-06-2513:25 ETSCHEDULE 13D/AOwnership report, active investor, amended0001437749-26-021656
2026-06-2311:52 ETSCHEDULE 13D/AOwnership report, active investor, amended0001185185-26-002614
2026-06-0416:06 ET8-K2.04 Item not in the standard list0001437749-26-019561
2026-05-1416:07 ET10-QQuarterly reportPeriod 2026-03-310001437749-26-017046

Latest annual report

Form 10-K for the fiscal year ended Dec 31, 2025Filed Mar 31, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by [object Promise].Forecast this quarter

About the filer

CIK
744825
Tickers
AMS
Exchange
NYSE
SIC code
8071 Services-Medical Laboratories
Sector
Healthcare
Fiscal year ends
Dec 31
Incorporated in
CA
Filer category
Non-accelerated filer<br>Smaller reporting company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:23 ET. Listed shows no prices and gives no investment advice.